Sareum Holdings PLC header image

Sareum Holdings PLC

SAR

Equity

ISIN GB00BMC3RJ87 / Valor 116566624

LSE London Stock Exchange, SETS (2026-08-06)

GBP 0.23%

Sareum Holdings PLC
UMushroom community rating:

5.00 1 votes No rating yet

NegativeNeutralPositive

About company

Sareum Holdings PLC is a clinical-stage biopharmaceutical company focused on the development of small molecule kinase inhibitors for the treatment of autoimmune diseases and cancer. The company's research and development efforts are centered on creating next-generation therapies that target specific kinases involved in disease pathways, aiming to provide more effective and targeted treatment options. Sareum leverages its expertise in medicinal chemistry and drug discovery to advance its pipeline of therapeutic candidates through preclinical and clinical stages, with the goal of addressing unmet medical needs in oncology and immunology.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

39.4%1Y

-75.9%3Y

-94.8%5Y

Performance

77.0%1Y

89.3%3Y

88.4%5Y

Volatility

43 M

Market cap (USD)

122,095

Daily traded volume (Shares)

0.27 / 0.27

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

5.00

1 votes

Performance:

3.00

Innovation:

5.00

Society:

5.00

Nature:

5.00

Lukas Mykhnenko

UK, 20 Oct 2025

potential breakthrough

EQUITIES OF THE SAME SECTOR

Insmed Inc

Insmed Inc Valor: 12614415

Annual Return

-50%0%+50%

Risk level

110

33.86%USD 132.55

GSK PLC

GSK PLC Valor: 119642297

Annual Return

-50%0%+50%

Risk level

110

1.10%GBP 19.36

Smith & Nephew PLC

Smith & Nephew PLC Valor: 1103058

Annual Return

-50%0%+50%

Risk level

110

-0.95%GBP 10.98

MEDICLIN AG

MEDICLIN AG Valor: 1158721

Annual Return

-50%0%+50%

Risk level

110

-2.31%EUR 4.22

Indivior PLC

Indivior PLC Valor: 121550831

Annual Return

-50%0%+50%

Risk level

110

-0.06%GBP 28.72

Shield Therapeutics PLC

Shield Therapeutics PLC Valor: 29778101

Annual Return

-50%0%+50%

Risk level

110

-3.75%GBP 0.038

Laboratorios Farmaceuticos Rovi, SA

Laboratorios Farmaceuticos Rovi, SA Valor: 3591807

Annual Return

-50%0%+50%

Risk level

110

-0.09%EUR 58.60

Ste Virbac SA

Ste Virbac SA Valor: 524407

Annual Return

-50%0%+50%

Risk level

110

1.48%EUR 343.50

Omnicell Inc

Omnicell Inc Valor: 1275961

Annual Return

-50%0%+50%

Risk level

110

-2.72%USD 36.16

Schrodinger Inc

Schrodinger Inc Valor: 51947209

Annual Return

-50%0%+50%

Risk level

110

8.60%USD 17.81

SIX

FactSet

Clearbit

Logos provided by Clearbit